Veriheal
MAY 26, 2022
Cannabis Advocacy With a Digital Twist. Much like RoC, patient advocacy is at the forefront of Veriheal’s work, which includes connecting patients with medical marijuana (MMJ) doctors, collecting patient data to improve future treatment, and battling harmful cannabis stigmas with education. “The
Cannabis Law Report
SEPTEMBER 23, 2022
SB 57 – which passed both houses – would have created a pilot program for overdose prevention sites in San Francisco, Oakland, and Los Angeles as an evidence-based intervention to curb drug overdose deaths. Policy and Advocacy Director, MAPS . Ismail Lourido Ali, J.D. ABOUT MAPS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
SEPTEMBER 17, 2021
Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Wesana outlined five key goals: Gain expertise and information to design psychedelic-assisted therapy programs for TBI and improve the Wesana timeline and path to market for its treatments.
Otherside Farms
JANUARY 25, 2019
Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.
Cannabis Law Report
DECEMBER 3, 2021
We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We
Cannabis Law Report
JANUARY 12, 2022
According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.
MMJ Recs
DECEMBER 22, 2023
Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.
Expert insights. Personalized for you.
96 
Let's personalize your content